CFI INTRODUCES NEW HANDS-ON TRAINING SEMINAR AT MELROSE ARCH
CFI Financial Group, a leading global online trading provider, will host its next seminar for both new and experienced traders on Tuesday, 25 November...
CFI brings volatility-trading seminar to Durban
CFI Financial Group, a leading global online trading provider, will host the next session in its education series,’ Trading Strategies for Volatile Times,’ on...
CFI Tops $1.55 Trillion in Q3 Trading Volume, Sets New Monthly...
CFI Financial Group, the region’s leading online trading provider, continues its upward trajectory, closing Q3 2025 with USD 1.55 trillion in trading volume, marking...
BiomX Provides a Program Update and Announces New FDA
BiomX believes that it has fully addressed the FDA’s queries related to the third-party nebulizer used to deliver BX004, which are narrow in scope;...
Adcytherix Raises EUR 105M Series A to Accelerate
Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads Financing led by Bpifrance with...
THEON strengthens transatlantic defense cooperation at AUSA
PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) Washington, D.C. - October 16, 2025. THEON, a global market leader in night...
Entera Bio to Present New Clinical Data from Phase 2 Trial
JERUSALEM, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein...
EyePoint Announces Proposed Public Offering of Common
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics...
Collegium to Celebrate 10-Year Anniversary with Nasdaq
STOUGHTON, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management team will ring the...
Salarius Pharmaceuticals Regains Compliance with All Nasdaq
HOUSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on October 10, 2025...
THEON plans to acquire 9.8% stake in Exosens
PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 11 October 2025 – Theon International Plc (THEON) has entered into a definitive...
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq
CAMBRIDGE, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules...










